OrthoPediatrics Corp. 8-K Summary
Business Context and Reporting Period
OrthoPediatrics Corp. (Nasdaq: KIDS) filed a Current Report on Form 8-K on April 30, 2026. The filing announces the results of operations for the quarter ended March 31, 2026. The company is incorporated in Delaware and operates from Warsaw, Indiana.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the unaudited condensed consolidated financial statements furnished as Exhibit 99.1 (the press release), which is incorporated by reference but not detailed in the body of this 8-K.
Material Changes
The filing does not explicitly detail material changes versus the prior comparable period. It serves as a notification that earnings results for the quarter ended March 31, 2026, have been issued.
Guidance, Outlook, and Risks
The filing text does not contain specific guidance, outlook, management commentary, risks, contingencies, or unusual items. Such information is referenced as being included in the press release (Exhibit 99.1).
Key Facts for Investor Verification
- Review Exhibit 99.1 (Press Release) for actual financial results for the quarter ended March 31, 2026.
- Verify the unaudited condensed consolidated financial statements included in the press release.
- Check for any forward-looking statements or guidance provided in the referenced press release.
- Confirm the trading symbol remains KIDS on the Nasdaq Global Market.